UGenome AI Announces Partnership with KonAnBio to Expand Bioinformatics Service Offerings

by | Jul 12, 2025 | Bioinformatics Services, Genomic analysis, News, Precision Health Personalized Medicine

for immediate release

TUCSON, A.Z. – UGenome AI, a pioneer in genomic platforms to fuel personalized medicine, today announced a referral partnership with KonAnbio, to expand each others’ bioinformatics capabilities. This partnership helps UGenome AI and KonAnbio offer a higher throughput and quality of bioinformatics services to their respective partners and clients.

Bioinformatics, at the intersection of biology, computer science, and statistics, is facing increasingly complex challenges as the volume and diversity of biological data explode. The volume of data with the scale of high-throughput sequencing technologies runs up against the heterogeneity of data that has to be curated with numerous overlapping computational structures. In addition, deriving reliable performance metrics (McBride, 2025) given AI and ML learning algorithms, single-cell and spatial transcriptomics datasets test storage infrastructure capacities and regulatory compliance such as GDPR add stretch storage complexity further (Bioinformatics Services Market Size | Industry Report, 2030, 2024), and the skills gap mean that the demand for expertise exceeds supply of bioinformaticians (Tammi, 2022).

“Combining data analysis services with software tools in computational biology is an ongoing evolution to make complexity of biological data more manageable, more actionable, and more meaningful to carry the baton during this generation to help future generations reduce some of the burdens of acute and chronic conditions. By leveraging strengths from one another, KonAnbio and UGenome AI can help fill these gaps,”said Zachary Brooks, PhD, founder and CEO of UGenome AI.

KonAnbio specialises in bioinformatics solutions, providing healthcare practitioners with flexible and customizable services required to effectively analyse and manage vast quantities of data. KonAnbio offers standalone or in conjunction with our Next Generation Sequencing Services using leading-edge technology to put science into improving human health.

“Partnering with UGenome marks a significant milestone for us. This collaboration reflects our shared vision of advancing precision bioinformatics and unlocking new possibilities in multi-omics research. Together, we aim to drive innovation, deliver real-world impact, and shape the future of personalized medicine,” said Kalliopi-Maria Stathopoulou, the CEO at KonAnbio.

“This partnership with KonAnBio will help UGenome fill the gaps in our current bioinformatics offerings. With the expanded bioinformatics offerings, we can broaden our client base and offer a variety of high-quality bioinformatics services,” said Jayden Lee, EMBA, PharmD, UGenome’s Chief Genomics Officer.

#######

About UGenome AI

UGenome AI is a startup biotech company focusing on developing genomics software. UGenome AI is advancing genomics analysis and helping patients receive personalized care, faster. Our products stem from our personalized reference genome and pharmacogenomics tools to help patients receive personalized treatments within weeks, not years. For more information, please visit www.ugenome.io.

About KonAnBio

KonAnBio provides complete end-to-end bioinformatics solutions for next-generation sequencing (NGS) to scientists from all over the world. With a strong background in big data analysis and pipeline development using machine learning algorithms and genomic tools, KonAnBio aims to provide high-quality, and flexible services for all your sequencing or array needs.

Contacts

For UGenome AI Inquiries:

Zachary Brooks

[email protected]

For KonAnBio Inquiries

Kalliopi Maria Stathopoulou

[email protected]

For Media:

Emma Bardin

[email protected]

References